• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

秋水仙碱:利与弊,以及如何将风险最小化。

Colchicine: the good, the bad, the ugly and how to minimize the risks.

机构信息

Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand.

Critical Care Complex, Middlemore Hospital, Auckland, New Zealand.

出版信息

Rheumatology (Oxford). 2024 Apr 2;63(4):936-944. doi: 10.1093/rheumatology/kead625.

DOI:10.1093/rheumatology/kead625
PMID:38019947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10986813/
Abstract

Colchicine has an important role in managing various conditions, including gout, familial Mediterranean fever, amyloidosis, Behçet's syndrome, recurrent pericarditis and calcium pyrophosphate deposition disease. The adverse effect profile of colchicine is well understood. However, due to its narrow therapeutic index, colchicine has been associated with overdose and fatalities. When ingested in toxic amounts, the mainstay of management is supportive care. Strategies to minimize the risk of colchicine poisoning can focus on three broad causes: unauthorized access, intentional overdose and inappropriate dosing. Culturally safe and appropriate education about storage and appropriate use of colchicine is essential to minimize the risk of overdose.

摘要

秋水仙碱在治疗多种疾病方面具有重要作用,包括痛风、家族性地中海热、淀粉样变性、贝切特综合征、复发性心包炎和焦磷酸钙沉积病。秋水仙碱的不良反应谱已经得到充分了解。然而,由于其治疗指数较窄,秋水仙碱与过量用药和死亡相关。当摄入有毒量时,主要的治疗方法是支持性护理。减少秋水仙碱中毒风险的策略可以集中在三个广泛的原因上:未经授权的获取、故意过量用药和不适当的剂量。关于秋水仙碱的储存和正确使用的文化上安全且合适的教育对于降低用药过量的风险至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d089/10986813/7842f21d01be/kead625f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d089/10986813/7842f21d01be/kead625f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d089/10986813/7842f21d01be/kead625f1.jpg

相似文献

1
Colchicine: the good, the bad, the ugly and how to minimize the risks.秋水仙碱:利与弊,以及如何将风险最小化。
Rheumatology (Oxford). 2024 Apr 2;63(4):936-944. doi: 10.1093/rheumatology/kead625.
2
Colchicine in clinical medicine. A guide for internists.秋水仙碱在临床医学中的应用。内科医师指南。
Eur J Intern Med. 2010 Dec;21(6):503-8. doi: 10.1016/j.ejim.2010.09.010. Epub 2010 Nov 5.
3
Colchicine: 1998 update.秋水仙碱:1998年更新版。
Semin Arthritis Rheum. 1998 Aug;28(1):48-59. doi: 10.1016/s0049-0172(98)80028-0.
4
Colchicine poisoning: the dark side of an ancient drug.秋水仙碱中毒:一种古老药物的黑暗面。
Clin Toxicol (Phila). 2010 Jun;48(5):407-14. doi: 10.3109/15563650.2010.495348.
5
Colchicine: An Ancient Drug with Multiple Benefits.秋水仙碱:一种具有多种益处的古老药物。
Curr Pharm Des. 2021;27(26):2917-2924. doi: 10.2174/1381612826666201023144320.
6
Colchicine: A Review on Chemical Structure and Clinical Usage.秋水仙碱:化学结构与临床应用综述
Infect Disord Drug Targets. 2018;18(2):105-121. doi: 10.2174/1871526517666171017114901.
7
Azoospermia in familial Mediterranean fever patients: the role of colchicine and amyloidosis.家族性地中海热患者的无精子症:秋水仙碱和淀粉样变性的作用。
Ann Rheum Dis. 1998 Apr;57(4):259-60. doi: 10.1136/ard.57.4.259.
8
Colchicine-induced myoneuropathy in childhood.秋水仙碱诱发的儿童期肌神经病
Eur J Pediatr. 1998 Oct;157(10):853-5. doi: 10.1007/s004310050952.
9
Isolating Colchicine in 19th Century: An Old Drug Revisited.19 世纪的秋水仙素提取:一种被重新审视的老药。
Curr Pharm Des. 2018;24(6):654-658. doi: 10.2174/1381612824666180115105850.
10
The effect of colchicine treatment on spermatozoa: a cytogenetic approach.秋水仙碱治疗对精子的影响:一种细胞遗传学方法。
J Assist Reprod Genet. 1999 Oct;16(9):504-7. doi: 10.1023/a:1020511318806.

引用本文的文献

1
Revitalizing Colchicine: Novel Delivery Platforms and Derivatives to Expand Its Therapeutic Potential.重振秋水仙碱:拓展其治疗潜力的新型给药平台与衍生物
Int J Mol Sci. 2025 Aug 6;26(15):7591. doi: 10.3390/ijms26157591.
2
CPI2 alleviates MSU-induced acute gouty arthritis in mice by inhibiting cathepsin S and the C5a-C5aR1 axis.CPI2通过抑制组织蛋白酶S和C5a-C5aR1轴来减轻小鼠体内由尿酸单钠诱导的急性痛风性关节炎。
Front Pharmacol. 2025 Jun 13;16:1604329. doi: 10.3389/fphar.2025.1604329. eCollection 2025.
3
Albendazole specifically disrupts microtubules and protein turnover in the tegument of the cestode Mesocestoides corti.

本文引用的文献

1
Evaluating the safety and short-term equivalence of colchicine versus prednisone in older patients with acute calcium pyrophosphate crystal arthritis (COLCHICORT): an open-label, multicentre, randomised trial.评价秋水仙碱与泼尼松在老年急性焦磷酸钙结晶关节炎患者中的安全性和短期等效性(COLCHICORT):一项开放标签、多中心、随机试验。
Lancet Rheumatol. 2023 Sep;5(9):e523-e531. doi: 10.1016/S2665-9913(23)00165-0. Epub 2023 Aug 8.
2
Delayed elimination in humans after ingestion of colchicine: Two fatal cases of colchicine poisoning.人类摄入秋水仙碱后的延迟消除:两例致命的秋水仙碱中毒案例。
J Forensic Sci. 2023 Jul;68(4):1425-1430. doi: 10.1111/1556-4029.15298. Epub 2023 May 30.
3
阿苯达唑特异性地破坏绦虫中殖孔绦虫皮层中的微管和蛋白质周转。
PLoS Pathog. 2025 Jun 4;21(6):e1013221. doi: 10.1371/journal.ppat.1013221. eCollection 2025 Jun.
4
[Colchicine-Phoenix from the ashes].[秋水仙碱——浴火重生]
Wien Klin Wochenschr. 2025 Feb;137(Suppl 1):1-33. doi: 10.1007/s00508-024-02490-7. Epub 2025 Feb 6.
5
Ectopic calcifications in the musculoskeletal field: the basis for preventive and curative pharmacological strategies.肌肉骨骼系统的异位钙化:预防和治疗性药物策略的基础
Clin Rheumatol. 2025 Mar;44(3):869-886. doi: 10.1007/s10067-025-07335-w. Epub 2025 Jan 24.
6
Colchicine combination therapy increases treatment tolerance in patients with arthritis: A systematic review and meta-analysis.秋水仙碱联合疗法可提高关节炎患者的治疗耐受性:一项系统评价与荟萃分析。
PLoS One. 2024 Dec 30;19(12):e0316126. doi: 10.1371/journal.pone.0316126. eCollection 2024.
7
Efficacy and safety of 10 mg versus 30 mg of oral prednisolone for acute CPP crystal arthritis: findings of a randomized controlled trial.10mg 与 30mg 口服泼尼松龙治疗急性 CPP 晶体关节炎的疗效和安全性:一项随机对照试验的结果。
Clin Rheumatol. 2024 Dec;43(12):3879-3888. doi: 10.1007/s10067-024-07184-z. Epub 2024 Oct 16.
8
Colchicine-The Divine Medicine against COVID-19.秋水仙碱——对抗新冠病毒的神奇药物。
J Pers Med. 2024 Jul 16;14(7):756. doi: 10.3390/jpm14070756.
9
Delivery Strategies for Colchicine as a Critical Dose Drug: Reducing Toxicity and Enhancing Efficacy.秋水仙碱作为一种临界剂量药物的给药策略:降低毒性并提高疗效。
Pharmaceutics. 2024 Feb 3;16(2):222. doi: 10.3390/pharmaceutics16020222.
Confirmed Fatal Colchicine Poisoning in an Adolescent with Blood and Bile Concentrations-Implications for GI Decontamination?
确认青少年血液和胆汁中存在秋水仙碱中毒-胃肠去污有何影响?
J Med Toxicol. 2023 Jul;19(3):280-283. doi: 10.1007/s13181-023-00946-2. Epub 2023 May 24.
4
Drugs That Interact With Colchicine Via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS).通过抑制细胞色素P450 3A4和P-糖蛋白与秋水仙碱相互作用的药物:使用自发报告不良事件数据库(FAERS)进行信号检测分析
Ann Pharmacother. 2023 Oct;57(10):1137-1146. doi: 10.1177/10600280221148031. Epub 2023 Jan 23.
5
The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) Trial.多年低剂量秋水仙碱暴露对肝肾功能和血肌酸激酶水平的影响:来自低剂量秋水仙碱 2 期临床试验(LoDoCo2)的安全性观察。
Clin Drug Investig. 2022 Nov;42(11):977-985. doi: 10.1007/s40261-022-01209-8. Epub 2022 Oct 8.
6
The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist.2021 年 EULAR/美国风湿病学会关于白细胞介素-1 介导的自身炎症性疾病的诊断、管理和监测的要点考虑:冷球蛋白血症相关周期性综合征、肿瘤坏死因子受体相关周期性综合征、甲羟戊酸激酶缺乏症和白细胞介素-1 受体拮抗剂缺乏症。
Arthritis Rheumatol. 2022 Jul;74(7):1102-1121. doi: 10.1002/art.42139. Epub 2022 May 27.
7
Severe colchicine poisoning treated successfully with kidney replacement therapy and plasmapheresis: a case report.肾替代治疗和血浆置换成功治疗严重秋水仙碱中毒:一例报告
Toxicol Commun. 2022;6(1):47-51. doi: 10.1080/24734306.2022.2055817. Epub 2022 Mar 24.
8
Colchicine in Cardiovascular Disease: In-Depth Review.秋水仙碱在心血管疾病中的应用:深入综述。
Circulation. 2022 Jan 4;145(1):61-78. doi: 10.1161/CIRCULATIONAHA.121.056171. Epub 2021 Dec 29.
9
Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease.关于长期低剂量秋水仙碱在痛风和心血管疾病中的疗效和安全性的共识声明。
Am J Med. 2022 Jan;135(1):32-38. doi: 10.1016/j.amjmed.2021.07.025. Epub 2021 Aug 18.
10
Repurposing colchicine's journey in view of drug-to-drug interactions. A review.鉴于药物相互作用重新审视秋水仙碱的应用历程。一篇综述。
Toxicol Rep. 2021 Jul 9;8:1389-1393. doi: 10.1016/j.toxrep.2021.07.009. eCollection 2021.